homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

April 23, 2019

Alpine Immune Sciences

In Seattle, Alpine Immune Sciences appointed Dr. Stanford Peng as president and head of R&D. Peng was executive vice president of R&D and chief medical officer. Prior to joining Alpine in 2016, he was chief medical officer at StemCentrx, and executive medical director and head of inflammation and translational medicine at Seattle Genetics. He succeeds Dr. Mark Litton. Alpine focuses on immunotherapy to treat cancer, autoimmune/inflammatory and other disease.




Email or user name:
Password:
 
Forgot password? Click here.